Upper extremity 3‐dimensional reachable workspace analysis in dystrophinopathy using Kinect. Issue 3 (3rd June 2015)

• Record Type: Journal Article
• Authors: Han, Jay J.; Kurillo, Gregorij; Abresch, Richard T.; De Bie, Evan; Nicorici, Alina; Bajcsy, Ruzena
• Is Part Of: Muscle & nerve. Volume 52:Issue 3(2015:Sep.)
• Page Start: 344
• Page End: 355
• Publication Date: 2015-06-03
• Subjects: Neuromuscular diseases -- Periodicals; Muscles -- Periodicals; Nerves -- Periodicals; 616.74
• DOI: 10.1002/mus.24567
• Languages: English
• ISSNs: 0148-639X

Abstract

<abstract abstract-type="main"> <title>ABSTRACT</title> <p> <italic>Introduction</italic>: An innovative upper extremity 3‐dimensional (3D) reachable workspace outcome measure acquired using the Kinect sensor is applied toward Duchenne/Becker muscular dystrophy (DMD/BMD). The validity, sensitivity, and clinical meaningfulness of this novel outcome measure are examined. <italic>Methods</italic>: Upper extremity function assessment (Brooke scale and NeuroQOL questionnaire) and Kinect‐based reachable workspace analyses were conducted in 43 individuals with dystrophinopathy (30 DMD and 13 BMD, aged 7–60 years) and 46 controls (aged 6–68 years). <italic>Results</italic>: The reachable workspace measure reliably captured a wide range of upper extremity impairments encountered in both pediatric and adult, as well as ambulatory and non‐ambulatory individuals with dystrophinopathy. Reduced reachable workspaces were noted for the dystrophinopathy cohort compared with controls, and they correlated with Brooke grades. In addition, progressive reduction in reachable workspace correlated directly with worsening ability to perform activities of daily living, as self‐reported on the NeuroQOL. <italic>Conclusion</italic>: This study demonstrates the utility and potential of the novel sensor‐acquired reachable workspace outcome measure in dystrophinopathy. <italic>Muscle Nerve</italic> 52:344–355, 2015</p> </abstract>